[go: up one dir, main page]

ZA200801161B - Platelet aggregation inhibitor composition - Google Patents

Platelet aggregation inhibitor composition

Info

Publication number
ZA200801161B
ZA200801161B ZA200801161A ZA200801161A ZA200801161B ZA 200801161 B ZA200801161 B ZA 200801161B ZA 200801161 A ZA200801161 A ZA 200801161A ZA 200801161 A ZA200801161 A ZA 200801161A ZA 200801161 B ZA200801161 B ZA 200801161B
Authority
ZA
South Africa
Prior art keywords
platelet aggregation
inhibitor composition
aggregation inhibitor
composition
platelet
Prior art date
Application number
ZA200801161A
Other languages
English (en)
Inventor
Yoshida Shigeto
Sudo Toshiki
Original Assignee
Educational Foundation Jichi M
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Educational Foundation Jichi M, Otsuka Pharma Co Ltd filed Critical Educational Foundation Jichi M
Publication of ZA200801161B publication Critical patent/ZA200801161B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43563Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082Supracellular entities, e.g. tissue, organisms
    • G01N33/5088Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • General Physics & Mathematics (AREA)
ZA200801161A 2005-11-04 2006-11-02 Platelet aggregation inhibitor composition ZA200801161B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005320817 2005-11-04

Publications (1)

Publication Number Publication Date
ZA200801161B true ZA200801161B (en) 2009-08-26

Family

ID=38005983

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200801161A ZA200801161B (en) 2005-11-04 2006-11-02 Platelet aggregation inhibitor composition

Country Status (18)

Country Link
US (2) US8034763B2 (fr)
EP (2) EP2077328B1 (fr)
JP (1) JP4954204B2 (fr)
KR (1) KR101311570B1 (fr)
CN (2) CN102911264B (fr)
AR (1) AR057858A1 (fr)
AU (1) AU2006309543B2 (fr)
BR (1) BRPI0618194A2 (fr)
CA (1) CA2625106C (fr)
ES (2) ES2547380T3 (fr)
IL (2) IL188986A0 (fr)
MY (1) MY148135A (fr)
PH (1) PH12013502021B1 (fr)
RU (2) RU2434941C2 (fr)
SG (1) SG166817A1 (fr)
TW (1) TWI391143B (fr)
WO (1) WO2007052841A1 (fr)
ZA (1) ZA200801161B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108503692B (zh) * 2017-07-10 2019-12-31 昆明医科大学第一附属医院 一种促血小板聚集的多肽pep1
CN108503689B (zh) * 2017-07-10 2019-12-31 昆明医科大学第一附属医院 一种抗血小板聚集的多肽km6
CN110339344B (zh) * 2019-08-07 2022-12-30 上海交通大学医学院附属仁济医院 核受体Rev-erbα在制备抗血小板药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0662088T3 (da) * 1993-07-01 2002-02-25 Merck Patent Gmbh Inhibitor af kollagen-stimuleret blodpladeaggregering
JPH10505502A (ja) 1994-09-12 1998-06-02 シェーリング アクチェンゲゼルシャフト 修飾されたコラーゲン誘導血小板凝集阻害剤パリジピンの製法
RU2192857C1 (ru) * 2001-04-24 2002-11-20 Институт органической химии им. Н.Д. Зелинского РАН Ингибитор агрегации тромбоцитов, обладающий антиметастатическим действием
JP3648548B2 (ja) * 2001-10-15 2005-05-18 国立大学法人三重大学 血液凝固阻害活性を有するハマダラカ由来のAs−1蛋白質
JP3837519B2 (ja) 2002-10-02 2006-10-25 国立大学法人三重大学 血小板凝集阻害活性を有するブラジルサシガメ由来のTi−3蛋白質
JP3837518B2 (ja) 2002-10-02 2006-10-25 国立大学法人三重大学 血小板凝集阻害活性を有するブラジルサシガメ由来のTi−4蛋白質

Also Published As

Publication number Publication date
US20100004164A1 (en) 2010-01-07
EP1943337A4 (fr) 2008-12-03
US20120004186A1 (en) 2012-01-05
US8309512B2 (en) 2012-11-13
US8034763B2 (en) 2011-10-11
RU2557296C2 (ru) 2015-07-20
EP2077328B1 (fr) 2015-07-15
IL188986A0 (en) 2008-08-07
EP1943337B1 (fr) 2015-07-15
PH12013502021A1 (en) 2015-12-14
ES2547404T3 (es) 2015-10-06
ES2547380T3 (es) 2015-10-05
KR20080105024A (ko) 2008-12-03
CN101273128A (zh) 2008-09-24
CA2625106C (fr) 2016-08-02
IL228986A0 (en) 2013-12-31
RU2008122338A (ru) 2009-12-10
EP2077328A1 (fr) 2009-07-08
BRPI0618194A2 (pt) 2011-08-23
EP1943337A1 (fr) 2008-07-16
AU2006309543A1 (en) 2007-05-10
PH12013502021B1 (en) 2019-02-01
TW200735887A (en) 2007-10-01
AU2006309543B2 (en) 2012-01-19
MY148135A (en) 2013-02-28
CN101273128B (zh) 2012-11-21
CN102911264A (zh) 2013-02-06
JP2009514785A (ja) 2009-04-09
RU2011120138A (ru) 2012-11-27
CN102911264B (zh) 2014-03-19
JP4954204B2 (ja) 2012-06-13
AR057858A1 (es) 2007-12-19
HK1120074A1 (en) 2009-03-20
WO2007052841A1 (fr) 2007-05-10
CA2625106A1 (fr) 2007-05-10
RU2434941C2 (ru) 2011-11-27
KR101311570B1 (ko) 2013-09-26
SG166817A1 (en) 2010-12-29
TWI391143B (zh) 2013-04-01

Similar Documents

Publication Publication Date Title
IL185906A0 (en) Composition
IL184421A0 (en) Fertilizer-compatible composition
GB0522658D0 (en) Composition
PL1994114T3 (pl) Kompozycja czynnika chłodniczego
ZA200705932B (en) Fertilizer-compatible composition
GB0618435D0 (en) Composition
EP1956073A4 (fr) Composition d'huile pour machine frigorifique
GB0506044D0 (en) Composition
GB0507167D0 (en) Composition
GB0508250D0 (en) Composition
EP1847249A4 (fr) Composition de coloration capillaire
GB0611740D0 (en) Refrigerant compositions
ZA200707917B (en) Composition
EP1955078A4 (fr) Dosages d'agrégation plaquettaire
IL228986A0 (en) A preparation that inhibits the aggregation of blood platelets
EP1923446A4 (fr) Composition réfrigérante
EP1947129A4 (fr) Composition à polymérisation photoradicalaire et photocationique
EP1930391A4 (fr) Composition refrigerante
ZA200807386B (en) Refrigerant composition
GB0502341D0 (en) Composition
GB0513641D0 (en) Anti-egeing composition
GB0510286D0 (en) Composition
GB0620570D0 (en) Refrigerant composition
GB0525748D0 (en) Composition
GB0515638D0 (en) Composition